PubMed Health⌕ Search

PubMed · 8998221

The Cardiothoracic Outreach Programme--a pilot project.

Abstract

OBJECTIVE: To test the practicality, safety and benefits of major cardiothoracic surgery in two rural hospitals. DESIGN: Analysis of morbidity and mortality outcomes of a random collection of 35 patients, who underwent diverse surgical procedures. At each visit, the cardiothoracic team of Ga-Rankuwa Hospital-one surgeon, three registrars, two medical officers, six nurses, and four perfusionists-moved all equipment for major surgery, including bypass machines, to two small rural hospitals. Ga-Rankuwa Hospital, as a tertiary hospital attached to a medical school (Medical University of Southern Africa), mounted an outreach programme on a trial basis. The exercise was designed to render assistance, offer decentralised services, and test the skills of the cardiothoracic team in an environment where high-technology procedures have never been undertaken by the local health professionals. SETTING: Two rural hospitals, viz. Tintswalo and Mankweng, in the referral area of MEDUNSA, with no conventional ICU facilities. The support services for operative, pre-operative and postoperative care were very basic. The local personnel consisted only of general nurses and medical officers. None had experience of high-technology or complex theatre work. PARTICIPANTS: Thirty-five randomly selected patients of both sexes with ages ranging from 11 years to 64 years. Pre-operative diagnoses of diverse cardiac and lung conditions were made. The operations performed comprised 35 major procedures, including open heart operations and major lung procedures. The personnel comprised the MEDUNSA cardiothoracic team, who were assisted by local nurses. INTERVENTION AND OUTCOME: Thirty-five patients underwent 35 major procedures, all under general anaesthesia. Twenty cardiopulmonary bypasses were performed. There was 1 intra-operative death, due to low-output state. Intra-operative morbidity occurred in 2 of the 35 operations. These consisted of a cerebrovascular accident (CVA) (air embolism), and a temporary heart block. Late outcomes (after 1 week) were also analysed; the incidence was 1/35 operations. This was a CVA due to a left atrial appendage clot. Staff morale at the local hospital improved remarkably. The process of teaching the local professional nurses was surprisingly easy. Benefits included a decreased referral rate (100%), lower costs (transport, medicines, operations), excellent patient and community confidence in the work of the hospitals (increased hospital outpatient numbers), and political support (new tools, upgraded facilities and new equipment). RESULTS: The exercise was a resounding success in both measurable and general terms. All operations were successfully performed, with very low adverse outcomes (morbidity, mortality) and good quality of life for all the subjects. The safety and cost-effectiveness of cardiothoracic surgery under primitive conditions were demonstrated. The standard of patient care improved, and local staff acquired good basic skills in patient care. The referral patterns changed for the better and the confidence of the community in the services was enhanced. The risk/benefit ratio of the exercise was commendable. The feasibility of an extended service was encouraging.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Klein, S P Ramoroko, A G Jacobs, M D Bomela, K P Mokhobo, M L Mohlala. 1996. The Cardiothoracic Outreach Programme--a pilot project.. https://pubmed.ncbi.nlm.nih.gov/8998221/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Challenges in drug development for muscle disease: a stakeholders' meeting.

Current treatment benefits for patients with muscle disease are limited, but progress in legislative and scientific initiatives have set the stage for the development of new therapies. The MD-CARE Act (Public Law 107-84), which allocates federal resources to muscular dystrophy, was approved by Congress and signed into law by the President of the United States in 2001. This has shifted the emphasis toward translational research. To facilitate a push toward therapy for muscle disorders, the Muscular Dystrophy Association (MDA) sponsored a meeting with representatives from industry, the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and other government agencies and academia. Each contributed in different ways. The FDA helped define the necessary data to support investigational new drug (IND) applications including the design of proof-of-principle studies, outcome measures for clinical trials, and the pathway for developing surrogate measures for fast-tracking promising new drugs. The NIH, other government agencies, and the MDA described potential funding sources for translational research. Industry delineated a complementary role with academia, and academic investigators elucidated the current strengths and weaknesses of available clinical endpoints. The meeting provided a format for communication for diverse disciplines that usually have no common meeting ground, helping to lay the foundation for bringing products to market in a timely fashion.

Academic Medical Centers↗

Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.

BACKGROUND: Malaysia like many other countries worldwide uses spontaneous reporting systems as a mean of collecting data on suspected adverse drug reaction (ADR). However, compared to other countries, which use the system, the reporting rate in Malaysia is very low. Why some physicians do not report ADRs is not well understood. OBJECTIVE: To identify factors, which would predict physicians' failure to send ADR reports. DESIGN AND SETTING: Face-to-face interview using a structured questionnaire involving physicians working at the University of Malaya Medical Centre, Malaysia. RESULTS: About a third of the physicians in the Centre participated. Sixty-five of the 415 approached refused to participate. A high proportion of the respondents (81.4%) indicated that they had suspected an ADR but did not report it, while about 40% of the respondents were not aware of the existence of the national reporting system in Malaysia. Logistic regression modelling identified the variable 'ADR considered to be too trivial or too well known to report' as the strongest predictor of not reporting, followed by physicians' category and uncertainty that the reaction had been definitely caused by a drug. CONCLUSION: Important predictor variables, which limit physicians from reporting ADR in Malaysia, were related to uncertainty of types of reaction to report, lack of awareness about the existence, function and purpose of national ADR reporting. The findings could be useful for planning strategies to improve the reporting rate.

Academic Medical Centers↗